Aller au contenu

Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial.

Nom du journal : Lancet Healthy Longev

Année : 2024

Volume : 5

Page de départ : e392-e405

Auteurs: Guigay, J, Le Caer, H, Ferrand, FR, Geoffrois, L, Saada-Bouzid, E, Fayette, J & al,